{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:12:41Z","timestamp":1790763161990,"version":"4.1.0"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00210-023-02444-2","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T01:02:34Z","timestamp":1677891754000},"page":"1371-1398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The NMDA receptor antagonists memantine and ketamine as anti-migraine agents"],"prefix":"10.1007","volume":"396","author":[{"given":"Karolina","family":"Podkowa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Czarnacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Boro\u0144czyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Boro\u0144czyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Paprocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"issue":"10258","key":"2444_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"C Abbafati","year":"2020","unstructured":"Abbafati C, Machado DB, Cislaghi B, Salman OM, Karanikolos M, McKee M, Abbas KM et al (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. The Lancet 396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9","journal-title":"The Lancet"},{"issue":"7","key":"2444_CR2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1212\/WNL.0b013e3182824e66","volume":"80","author":"SK Afridi","year":"2013","unstructured":"Afridi SK, Giffin NJ, Kaube H, Goadsby PJ (2013) A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology 80(7):642\u2013647. https:\/\/doi.org\/10.1212\/WNL.0b013e3182824e66","journal-title":"Neurology"},{"issue":"1","key":"2444_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/s0022-510x(98)00023-9","volume":"156","author":"Z Alam","year":"1998","unstructured":"Alam Z, Coombes N, Waring RH, Williams AC, Steventon GB (1998) Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J Neurol Sci 156(1):102\u2013106. https:\/\/doi.org\/10.1016\/s0022-510x(98)00023-9","journal-title":"J Neurol Sci"},{"issue":"4","key":"2444_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1503\/jpn.160175","volume":"42","author":"LR Aleksandrova","year":"2017","unstructured":"Aleksandrova LR, Phillips AG, Wang YT (2017) Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism. J Psychiatry Neurosci 42(4):222\u2013229. https:\/\/doi.org\/10.1503\/jpn.160175","journal-title":"J Psychiatry Neurosci"},{"issue":"1\u20132","key":"2444_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0006-8993(90)90101-G","volume":"519","author":"T Amemori","year":"1990","unstructured":"Amemori T, Bures J (1990) Ketamine Blockade of spreading depression: rapid development of tolerance. Brain Res 519(1\u20132):351\u2013354. https:\/\/doi.org\/10.1016\/0006-8993(90)90101-G","journal-title":"Brain Res"},{"issue":"2","key":"2444_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","volume":"79","author":"NA Anis","year":"1983","unstructured":"Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 79(2):565\u2013575. https:\/\/doi.org\/10.1111\/j.1476-5381.1983.tb11031.x","journal-title":"Br J Pharmacol"},{"issue":"19","key":"2444_CR7","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M (2020) Migraine. N Engl J Med 383(19):1866\u20131876. https:\/\/doi.org\/10.1056\/NEJMra1915327","journal-title":"N Engl J Med"},{"issue":"10","key":"2444_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41582-019-0243-8","volume":"15","author":"H Ashina","year":"2019","unstructured":"Ashina H, Porreca F, Anderson T, Amin FM, Ashina M, Schytz HW, Dodick DW (2019) Post-traumatic headache: epidemiology and pathophysiological insights. Nat Rev Neurol 15(10):607\u2013617. https:\/\/doi.org\/10.1038\/s41582-019-0243-8","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2444_CR9","first-page":"791","volume":"16","author":"F Assarzadegan","year":"2017","unstructured":"Assarzadegan F, Sistanizad M (2017) Tolerability and efficacy of memantine as add on therapy in patients with migraine. Iran J Pharm Res 16(2):791\u2013797","journal-title":"Iran J Pharm Res"},{"issue":"4","key":"2444_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1526-4610.2010.01647.x","volume":"50","author":"C Ayata","year":"2010","unstructured":"Ayata C (2010) Cortical spreading depression triggers migraine attack: pro. Headache 50(4):725\u2013730. https:\/\/doi.org\/10.1111\/j.1526-4610.2010.01647.x","journal-title":"Headache"},{"issue":"3","key":"2444_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20161673","volume":"214","author":"H Bading","year":"2017","unstructured":"Bading H (2017) Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations. J Exp Med 214(3):569\u2013578. https:\/\/doi.org\/10.1084\/jem.20161673","journal-title":"J Exp Med"},{"issue":"January","key":"2444_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","volume":"278","author":"A Bahji","year":"2021","unstructured":"Bahji A, Vazquez GH, Zarate CA Jr (2021) Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis. J Affect Disord 278(January):542\u201355. https:\/\/doi.org\/10.1016\/j.jad.2020.09.071","journal-title":"J Affect Disord"},{"issue":"8","key":"2444_CR13","doi-asserted-by":"publisher","first-page":"a022863","DOI":"10.1101\/cshperspect.a022863","volume":"5","author":"M Barker-Haliski","year":"2015","unstructured":"Barker-Haliski M, Steve White H (2015) Glutamatergic mechanisms associated with seizures and epilepsy. Cold Spring Harb Perspect Med 5(8):a022863\u2013a022863. https:\/\/doi.org\/10.1101\/cshperspect.a022863","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"2444_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/ACO.0000000000000916","volume":"33","author":"W Barrett","year":"2020","unstructured":"Barrett W, Buxhoeveden M, Dhillon S (2020) Ketamine: a versatile tool for anesthesia and analgesia. Curr Opin Anaesthesiol 33(5):633\u2013638. https:\/\/doi.org\/10.1097\/ACO.0000000000000916","journal-title":"Curr Opin Anaesthesiol"},{"issue":"12","key":"2444_CR15","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1016\/j.clinph.2020.09.016","volume":"131","author":"ZJR Bastany","year":"2020","unstructured":"Bastany ZJR, Askari S, Dumont GA, Kellinghaus C, Kazemi A, Gorji A (2020) Association of cortical spreading depression and seizures in patients with medically intractable epilepsy. Clin Neurophysiol 131(12):2861\u20132874. https:\/\/doi.org\/10.1016\/j.clinph.2020.09.016","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"2444_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/0333102412439354","volume":"32","author":"M Baun","year":"2012","unstructured":"Baun M, Pedersen MHF, Olesen J, Jansen-Olesen I (2012) Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia 32(4):337\u2013345. https:\/\/doi.org\/10.1177\/0333102412439354","journal-title":"Cephalalgia"},{"issue":"December","key":"2444_CR17","doi-asserted-by":"publisher","first-page":"RRN1291","DOI":"10.1371\/currents.RRN1291","volume":"3","author":"MG Beconi","year":"2011","unstructured":"Beconi MG, Howland D, Park L, Lyons K, Giuliano J, Dominguez C, Munoz-Sanjuan I, Pacifici R (2011) Pharmacokinetics of memantine in rats and mice. PLoS Currents 3(December):RRN1291. https:\/\/doi.org\/10.1371\/currents.RRN1291","journal-title":"PLoS Currents"},{"issue":"Pt C","key":"2444_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.neuropharm.2013.04.024","volume":"76","author":"P Bekinschtein","year":"2014","unstructured":"Bekinschtein P, Cammarota M, Medina JH (2014) BDNF and memory processing. Neuropharmacology 76(Pt C):677\u2013683. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.04.024","journal-title":"Neuropharmacology"},{"issue":"3","key":"2444_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jemermed.2018.12.007","volume":"56","author":"T Benish","year":"2019","unstructured":"Benish T, Villalobos D, Love S, Casmaer M, Hunter CJ, Summers SM, April MD (2019) The THINK (Treatment of Headache with Intranasal Ketamine) trial: a randomized controlled trial comparing intranasal ketamine with intravenous metoclopramide. J Emerg Med 56(3):248\u2013257. https:\/\/doi.org\/10.1016\/j.jemermed.2018.12.007","journal-title":"J Emerg Med"},{"issue":"9","key":"2444_CR20","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/j.1526-4610.2008.01083.x","volume":"48","author":"M Bigal","year":"2008","unstructured":"Bigal M, Rapoport A, Sheftell F, Tepper D, Tepper S (2008) Memantine in the preventive treatment of refractory migraine. Headache 48(9):1337\u20131342. https:\/\/doi.org\/10.1111\/j.1526-4610.2008.01083.x","journal-title":"Headache"},{"issue":"5","key":"2444_CR21","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.semcdb.2006.10.008","volume":"17","author":"D Bleakman","year":"2006","unstructured":"Bleakman D, Alt A, Nisenbaum ES (2006) Glutamate receptors and pain. Semin Cell Dev Biol 17(5):592\u2013604. https:\/\/doi.org\/10.1016\/j.semcdb.2006.10.008","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"2444_CR22","first-page":"1125","volume":"252","author":"NR Boisse","year":"1990","unstructured":"Boisse NR, Quaglietta N, Samoriski GM, Guarino JJ (1990) Tolerance and physical dependence to a short-acting benzodiazepine, midazolam. J Pharmacol Exp Ther 252(3):1125\u20131133","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2444_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s10194-019-1042-8","volume":"20","author":"H Bolay","year":"2019","unstructured":"Bolay H, Vuralli D, Goadsby PJ (2019) Aura and head pain: relationship and gaps in the translational models. J Headache Pain 20(1):94. https:\/\/doi.org\/10.1186\/s10194-019-1042-8","journal-title":"J Headache Pain"},{"key":"2444_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.conb.2017.12.020","volume":"51","author":"G Bouvier","year":"2018","unstructured":"Bouvier G, Larsen RS, Rodr\u00edguez-Moreno A, Paulsen O, Sj\u00f6str\u00f6m PJ (2018) Towards resolving the presynaptic NMDA receptor debate. Curr Opin Neurobiol 51:1\u20137. https:\/\/doi.org\/10.1016\/j.conb.2017.12.020","journal-title":"Curr Opin Neurobiol"},{"key":"2444_CR25","doi-asserted-by":"publisher","first-page":"108683","DOI":"10.1016\/j.neuropharm.2021.108683","volume":"196","author":"Ananth Prasad Burada","year":"2021","unstructured":"Burada Ananth Prasad, Vinnakota Rajesh, Lambolez Bertrand, Tricoire Ludovic, Kumar Janesh (2021) Structural biology of ionotropic glutamate delta receptors and their crosstalk with metabotropic glutamate receptors. Neuropharmacology 196:108683. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108683","journal-title":"Neuropharmacology"},{"issue":"4","key":"2444_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","volume":"37","author":"RC Burch","year":"2019","unstructured":"Burch RC, Buse DC, Lipton RB (2019) Migraine: epidemiology, burden, and comorbidity. Neurol Clin 37(4):631\u2013649. https:\/\/doi.org\/10.1016\/j.ncl.2019.06.001","journal-title":"Neurol Clin"},{"issue":"1","key":"2444_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10194-020-1084-y","volume":"21","author":"DC Buse","year":"2020","unstructured":"Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, Munjal S, Singh P, Lipton RB (2020) Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain 21(1):23. https:\/\/doi.org\/10.1186\/s10194-020-1084-y","journal-title":"J Headache Pain"},{"issue":"1","key":"2444_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/(sici)1099-1166(199901)14:1<3::aid-gps897>3.0.co;2-7","volume":"14","author":"R Cacabelos","year":"1999","unstructured":"Cacabelos R, Takeda M, Winblad B (1999) The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer\u2019s disease. Int J Geriatr Psychiatry 14(1):3\u201347. https:\/\/doi.org\/10.1002\/(sici)1099-1166(199901)14:1%3c3::aid-gps897%3e3.0.co;2-7","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6","key":"2444_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.1526-4610.2005.00805.x","volume":"45","author":"D Cammarata","year":"2005","unstructured":"Cammarata D, Krusz JC (2005) Memantine: novel mechanism for migraine and headache prophylaxis. Headache 45(6):820. https:\/\/doi.org\/10.1111\/j.1526-4610.2005.00805.x","journal-title":"Headache"},{"issue":"2","key":"2444_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1046\/j.1468-2982.1995.015002132.x","volume":"15","author":"AR Cananzi","year":"1995","unstructured":"Cananzi AR, D\u2019Andrea G, Perini F, Zamberlan F, Welch KM (1995) Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia 15(2):132\u2013135. https:\/\/doi.org\/10.1046\/j.1468-2982.1995.015002132.x","journal-title":"Cephalalgia"},{"issue":"5","key":"2444_CR31","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3171\/2017.12.JNS171665","volume":"130","author":"AP Carlson","year":"2019","unstructured":"Carlson AP, Abbas M, Alunday RL, Qeadan F, William Shuttleworth C (2019) Spreading depolarization in acute brain injury inhibited by ketamine: a prospective, randomized, multiple crossover trial. J Neurosurg 130(5):1513\u20131519. https:\/\/doi.org\/10.3171\/2017.12.JNS171665","journal-title":"J Neurosurg"},{"key":"2444_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0072-9752(10)97007-3","volume":"97","author":"A Charles","year":"2010","unstructured":"Charles A, Brennan KC (2010) The neurobiology of migraine. Handb Clin Neurol 97:99\u2013108. https:\/\/doi.org\/10.1016\/S0072-9752(10)97007-3","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"2444_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s10194-007-0406-7","volume":"8","author":"A Charles","year":"2007","unstructured":"Charles A, Flippen C, Reyes MR, Brennan KC (2007) Memantine for prevention of migraine: a retrospective study of 60 cases. J Headache Pain 8(4):248\u2013250. https:\/\/doi.org\/10.1007\/s10194-007-0406-7","journal-title":"J Headache Pain"},{"issue":"7","key":"2444_CR34","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tcm.2019.10.005","volume":"30","author":"D Chen","year":"2020","unstructured":"Chen D, Willis-Parker M, Lundberg GP (2020) Migraine headache: is it only a neurological disorder? Links between migraine and cardiovascular disorders. Trends Cardiovasc Med 30(7):424\u2013430. https:\/\/doi.org\/10.1016\/j.tcm.2019.10.005","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"2444_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11916-018-0693-5","volume":"22","author":"T-M Chou","year":"2018","unstructured":"Chou T-M, Chen S-P (2018) Animal models of chronic migraine. Curr Pain Headache Rep 22(6):44. https:\/\/doi.org\/10.1007\/s11916-018-0693-5","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"2444_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/sj.npp.1301559","volume":"33","author":"A Citri","year":"2008","unstructured":"Citri A, Malenka RC (2008) Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 33(1):18\u201341. https:\/\/doi.org\/10.1038\/sj.npp.1301559","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"2444_CR37","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/acem.13428","volume":"25","author":"EJ Clattenburg","year":"2018","unstructured":"Clattenburg EJ, Hailozian C, Haro D, Yoo T, Flores S, Louie D, Herring AA (2018) Slow infusion of low-dose ketamine reduces bothersome side effects compared to intravenous push: a double-blind, double-dummy, randomized controlled trial. Acad Emerg Med off J Soc Acad Emerg Med 25(9):1048\u20131052. https:\/\/doi.org\/10.1111\/acem.13428","journal-title":"Acad Emerg Med off J Soc Acad Emerg Med"},{"issue":"5","key":"2444_CR38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/jps.2600710516","volume":"71","author":"JA Clements","year":"1982","unstructured":"Clements JA, Nimmo WS, Grant IS (1982) Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci 71(5):539\u2013542. https:\/\/doi.org\/10.1002\/jps.2600710516","journal-title":"J Pharm Sci"},{"key":"2444_CR39","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.2147\/DDDT.S221437","volume":"13","author":"A Corriger","year":"2019","unstructured":"Corriger A, Pickering G (2019) Ketamine and depression: a narrative review. Drug Des Dev Ther 13:3051\u20133067. https:\/\/doi.org\/10.2147\/DDDT.S221437","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"2444_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1129-2377-14-62","volume":"14","author":"C Costa","year":"2013","unstructured":"Costa C, Tozzi A, Rainero I, Cupini LM, Calabresi P, Ayata C, Sarchielli P (2013) Cortical spreading depression as a target for anti-migraine agents. J Headache Pain 14(1):62. https:\/\/doi.org\/10.1186\/1129-2377-14-62","journal-title":"J Headache Pain"},{"issue":"4","key":"2444_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1046\/j.1468-2982.1991.1104197.x","volume":"11","author":"G D\u2019Andrea","year":"1991","unstructured":"D\u2019Andrea G, Cananzi AR, Joseph R, Morra M, Zamberlan F, Ferro Milone F, Grunfeld S, Welch KM (1991) Platelet glycine, glutamate and aspartate in primary headache. Cephalalgia 11(4):197\u2013200. https:\/\/doi.org\/10.1046\/j.1468-2982.1991.1104197.x","journal-title":"Cephalalgia"},{"issue":"6","key":"2444_CR42","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1046\/j.1468-2982.1997.1706652.x","volume":"17","author":"P D\u2019Eufemia","year":"1997","unstructured":"D\u2019Eufemia P, Finocchiaro R, Lendvai D, Celli M, Viozzi L, Troiani P, Turri E, Giardini O (1997) Erythrocyte and plasma levels of glutamate and aspartate in children affected by migraine. Cephalalgia 17(6):652\u2013657. https:\/\/doi.org\/10.1046\/j.1468-2982.1997.1706652.x","journal-title":"Cephalalgia"},{"key":"2444_CR43","doi-asserted-by":"publisher","unstructured":"de Vries T, Villal\u00f3n CM, MaassenVanDenBrink A (2020) Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans. Pharmacol Ther 211:107528. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107528","DOI":"10.1016\/j.pharmthera.2020.107528"},{"issue":"21","key":"2444_CR44","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1523\/JNEUROSCI.2526-13.2014","volume":"34","author":"MN Di Guilmi","year":"2014","unstructured":"Di Guilmi MN, Wang T, Gonzalez Inchauspe C, Forsythe ID, Ferrari MD, van den Maagdenberg AMJM, Borst JGG, Uchitel OD (2014) Synaptic gain-of-function effects of mutant Cav2.1 channels in a mouse model of familial hemiplegic migraine are due to increased basal [Ca2+]i. J Neurosci 34(21):7047\u201358. https:\/\/doi.org\/10.1523\/JNEUROSCI.2526-13.2014","journal-title":"J Neurosci"},{"issue":"3","key":"2444_CR45","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/WNO.0000000000000837","volume":"39","author":"KB Digre","year":"2019","unstructured":"Digre KB (2019) What\u2019s new in the treatment of migraine? J Neuro-Ophthalmol 39(3):352\u2013359. https:\/\/doi.org\/10.1097\/WNO.0000000000000837","journal-title":"J Neuro-Ophthalmol"},{"key":"2444_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2150132720963680","volume":"11","author":"DW Dodick","year":"2020","unstructured":"Dodick DW, Shewale AS, Lipton RB, Baum SJ, Marcus SC, Silberstein SD, Pavlovic JM et al (2020) Migraine patients with cardiovascular disease and contraindications: an analysis of real-world claims data. J Prim Care Community Health 11:1\u201310. https:\/\/doi.org\/10.1177\/2150132720963680","journal-title":"J Prim Care Community Health"},{"key":"2444_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/cpt196563279","volume":"6","author":"EF Domino","year":"1965","unstructured":"Domino EF, Chodoff P, Corssen G (1965) Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther 6:279\u2013291","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"2444_CR48","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1526-4610.2006.00483.x","volume":"46","author":"Paul L Durham","year":"2006","unstructured":"Durham Paul L (2006) Calcitonin gene-related peptide (CGRP) and migraine. Headache 46(Suppl 1):S3\u2013S8. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00483.x","journal-title":"Headache"},{"issue":"9","key":"2444_CR49","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/nejm199403033300907","volume":"330","author":"FH Epstein","year":"1994","unstructured":"Epstein FH, Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330(9):613\u2013622. https:\/\/doi.org\/10.1056\/nejm199403033300907","journal-title":"N Engl J Med"},{"issue":"6","key":"2444_CR50","doi-asserted-by":"publisher","first-page":"952","DOI":"10.5811\/westjem.2018.8.37875","volume":"19","author":"AR Etchison","year":"2018","unstructured":"Etchison AR, Bos L, Ray M, McAllister KB, Mohammed M, Park B, Phan AV, Heitz C (2018) Low-dose ketamine does not improve migraine in the emergency department: a randomized placebo-controlled trial. West J Emerg Med 19(6):952\u2013960. https:\/\/doi.org\/10.5811\/westjem.2018.8.37875","journal-title":"West J Emerg Med"},{"issue":"2","key":"2444_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar JT, James P Jr, Young LL, Werth JL, Poole MR (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94(2):149\u2013158. https:\/\/doi.org\/10.1016\/S0304-3959(01)00349-9","journal-title":"Pain"},{"issue":"2","key":"2444_CR52","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2174\/157015911795596621","volume":"9","author":"A Fejes","year":"2011","unstructured":"Fejes A, P\u00e1rdutz A, Toldi J, V\u00e9csei L (2011) Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives. Curr Neuropharmacol 9(2):376\u2013387. https:\/\/doi.org\/10.2174\/157015911795596621","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"2444_CR53","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1212\/wnl.40.10.1582","volume":"40","author":"MD Ferrari","year":"1990","unstructured":"Ferrari MD, Odink J, Bos KD, Malessy MJ, Bruyn GW (1990) Neuroexcitatory plasma amino acids are elevated in migraine. Neurology 40(10):1582\u20131586. https:\/\/doi.org\/10.1212\/wnl.40.10.1582","journal-title":"Neurology"},{"issue":"3","key":"2444_CR54","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-170672","volume":"62","author":"J Folch","year":"2018","unstructured":"Folch J, Busquets O, Ettcheto M, S\u00e1nchez-L\u00f3pez E, Castro-Torres RD, Verdaguer E, Garcia ML et al (2018) Memantine for the treatment of dementia: a review on its current and future applications. J Alzheimers Dis 62(3):1223\u20131240. https:\/\/doi.org\/10.3233\/JAD-170672","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"2444_CR55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.nrl.2017.09.014","volume":"36","author":"AB Gago-Veiga","year":"2021","unstructured":"Gago-Veiga AB, Vivancos J, Sobrado M (2021) The premonitory phase: a crucial stage in migraine. Neurologia 36(4):298\u2013304. https:\/\/doi.org\/10.1016\/j.nrl.2017.09.014","journal-title":"Neurologia"},{"issue":"3","key":"2444_CR56","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1468-2982.2003.00552.x","volume":"23","author":"V Gallai","year":"2003","unstructured":"Gallai V, Alberti A, Gallai B, Coppola F, Floridi A, Sarchielli P (2003) Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia 23(3):166\u2013174. https:\/\/doi.org\/10.1046\/j.1468-2982.2003.00552.x","journal-title":"Cephalalgia"},{"issue":"2","key":"2444_CR57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jpsychires.2012.09.015","volume":"47","author":"A Ghaleiha","year":"2013","unstructured":"Ghaleiha A, Entezari N, Modabbernia A, Najand B, Askari N, Tabrizi M, Ashrafi M, Hajiaghaee R, Akhondzadeh S (2013) Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study. J Psychiatr Res 47(2):175\u2013180. https:\/\/doi.org\/10.1016\/j.jpsychires.2012.09.015","journal-title":"J Psychiatr Res"},{"issue":"2","key":"2444_CR58","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553\u2013622. https:\/\/doi.org\/10.1152\/physrev.00034.2015","journal-title":"Physiol Rev"},{"issue":"4","key":"2444_CR59","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/0013-4694(87)90213-6","volume":"66","author":"NA Gorelova","year":"1987","unstructured":"Gorelova NA, Koroleva VI, Amemori T, Pavl\u00edk V, Bure\u0161 J (1987) Ketamine blockade of cortical spreading depression in rats. Electroencephalogr Clin Neurophysiol 66(4):440\u2013447. https:\/\/doi.org\/10.1016\/0013-4694(87)90213-6","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"2","key":"2444_CR60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4103\/0970-9185.182085","volume":"32","author":"AW Gorlin","year":"2016","unstructured":"Gorlin AW, Rosenfeld DM, Ramakrishna H (2016) Intravenous sub-anesthetic ketamine for perioperative analgesia. J Anaesthesiol Clin Pharmacol 32(2):160\u2013167. https:\/\/doi.org\/10.4103\/0970-9185.182085","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"1","key":"2444_CR61","first-page":"17","volume":"99","author":"H Ha","year":"2019","unstructured":"Ha H, Gonzalez A (2019) Migraine headache prophylaxis. Am Fam Physician 99(1):17\u201324","journal-title":"Am Fam Physician"},{"issue":"1","key":"2444_CR62","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s10194-019-0983-2","volume":"20","author":"N Hadjikhani","year":"2019","unstructured":"Hadjikhani N, Vincent M (2019) Neuroimaging clues of migraine aura. J Headache Pain 20(1):32. https:\/\/doi.org\/10.1186\/s10194-019-0983-2","journal-title":"J Headache Pain"},{"issue":"11","key":"2444_CR63","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/j.1468-2982.2007.01476.x","volume":"27","author":"E Hamel","year":"2007","unstructured":"Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27(11):1293\u20131300. https:\/\/doi.org\/10.1111\/j.1468-2982.2007.01476.x","journal-title":"Cephalalgia"},{"issue":"1864","key":"2444_CR64","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1098\/rsta.2007.2094","volume":"366","author":"W Hanke","year":"2008","unstructured":"Hanke W, Fernandes de Lima VM (2008) Central nervous tissue: an excitable medium. a study using the retinal spreading depression as a tool. Philos Trans A Math Phys Eng Sci 366(1864):359\u201368. https:\/\/doi.org\/10.1098\/rsta.2007.2094","journal-title":"Philos Trans A Math Phys Eng Sci"},{"issue":"5","key":"2444_CR65","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.neuron.2014.01.035","volume":"81","author":"KB Hansen","year":"2014","unstructured":"Hansen KB, Ogden KK, Yuan H, Traynelis SF (2014) Distinct functional and pharmacological properties of triheteromeric GluN1\/GluN2A\/GluN2B NMDA receptors. Neuron 81(5):1084\u20131096. https:\/\/doi.org\/10.1016\/j.neuron.2014.01.035","journal-title":"Neuron"},{"issue":"8","key":"2444_CR66","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1085\/jgp.201812032","volume":"150","author":"KB Hansen","year":"2018","unstructured":"Hansen KB, Yi F, Perszyk RE, Furukawa H, Wollmuth LP, Gibb AJ, Traynelis SF (2018) Structure, function, and allosteric modulation of NMDA receptors. J Gen Physiol 150(8):1081\u20131105. https:\/\/doi.org\/10.1085\/jgp.201812032","journal-title":"J Gen Physiol"},{"issue":"1","key":"2444_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s10194-019-1001-4","volume":"20","author":"AM Harriott","year":"2019","unstructured":"Harriott AM, Takizawa T, Chung DY, Chen S-P (2019) Spreading depression as a preclinical model of migraine. J Headache Pain 20(1):45. https:\/\/doi.org\/10.1186\/s10194-019-1001-4","journal-title":"J Headache Pain"},{"issue":"1","key":"2444_CR68","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12028-019-00777-6","volume":"32","author":"R Helbok","year":"2020","unstructured":"Helbok R, Hartings JA, Schiefecker A, Balan\u00e7a B, Jewel S, Foreman B, Ercole A et al (2020) What should a clinician do when spreading depolarizations are observed in a patient?\u201d. Neurocrit Care 32(1):306\u2013310. https:\/\/doi.org\/10.1007\/s12028-019-00777-6","journal-title":"Neurocrit Care"},{"issue":"2","key":"2444_CR69","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0006-8993(87)91652-0","volume":"437","author":"J Hern\u00e1nd\u00e9z-C\u00e1ceres","year":"1987","unstructured":"Hern\u00e1nd\u00e9z-C\u00e1ceres J, Macias-Gonz\u00e1lez R, Bro\u017eek G, Bure\u0161 J (1987) Systemic ketamine blocks cortical spreading depression but does not delay the onset of terminal anoxic depolarization in rats. Brain Res 437(2):360\u2013364. https:\/\/doi.org\/10.1016\/0006-8993(87)91652-0","journal-title":"Brain Res"},{"issue":"12","key":"2444_CR70","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1177\/0333102418761041","volume":"38","author":"ME Hiekkala","year":"2018","unstructured":"Hiekkala ME, Vuola P, Artto V, H\u00e4pp\u00f6l\u00e4 P, H\u00e4pp\u00f6l\u00e4 E, Veps\u00e4l\u00e4inen S, Cuenca-Le\u00f3n E et al (2018) The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: a clinical and genetic study in Finnish migraine families. Cephalalgia 38(12):1849\u20131863. https:\/\/doi.org\/10.1177\/0333102418761041","journal-title":"Cephalalgia"},{"issue":"2","key":"2444_CR71","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s13311-018-0616-5","volume":"15","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, Charles A (2018) Glutamate and its receptors as therapeutic targets for migraine. Neurotherapeutics 15(2):361\u2013370. https:\/\/doi.org\/10.1007\/s13311-018-0616-5","journal-title":"Neurotherapeutics"},{"issue":"5","key":"2444_CR72","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1111\/ejn.14423","volume":"50","author":"J Hoffmann","year":"2019","unstructured":"Hoffmann J, Storer RJ, Park J-W, Goadsby PJ (2019) N-Methyl-d-aspartate receptor open-channel blockers memantine and magnesium modulate nociceptive trigeminovascular neurotransmission in rats. Eur J Neurosci 50(5):2847\u20132859. https:\/\/doi.org\/10.1111\/ejn.14423","journal-title":"Eur J Neurosci"},{"issue":"5","key":"2444_CR73","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1177\/0271678X16645113","volume":"37","author":"T Houben","year":"2017","unstructured":"Houben T, Loonen IC, Baca SM, Schenke M, Meijer JH, Ferrari MD, Terwindt GM et al (2017) Optogenetic induction of cortical spreading depression in anesthetized and freely behaving mice. J Cereb Blood Flow Metab 37(5):1641\u20131655. https:\/\/doi.org\/10.1177\/0271678X16645113","journal-title":"J Cereb Blood Flow Metab"},{"issue":"48","key":"2444_CR74","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1523\/JNEUROSCI.1713-19.2019","volume":"39","author":"NA Jansen","year":"2019","unstructured":"Jansen NA, Schenke M, Voskuyl RA, Thijs RD, van den Maagdenberg AMJM, Tolner EA (2019) Apnea associated with brainstem seizures in Cacna1a (S218L) mice is caused by medullary spreading depolarization. J Neurosci 39(48):9633\u20139644. https:\/\/doi.org\/10.1523\/JNEUROSCI.1713-19.2019","journal-title":"J Neurosci"},{"issue":"6104","key":"2444_CR75","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/325529a0","volume":"325","author":"JW Johnson","year":"1987","unstructured":"Johnson JW, Ascher P (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325(6104):529\u2013531. https:\/\/doi.org\/10.1038\/325529a0","journal-title":"Nature"},{"issue":"1","key":"2444_CR76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","volume":"6","author":"JW Johnson","year":"2006","unstructured":"Johnson JW, Kotermanski SE (2006) Mechanism of action of memantine. Curr Opin Pharmacol 6(1):61\u201367. https:\/\/doi.org\/10.1016\/j.coph.2005.09.007","journal-title":"Curr Opin Pharmacol"},{"issue":"6123","key":"2444_CR77","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.1231897","volume":"339","author":"H Karatas","year":"2013","unstructured":"Karatas H, Erdener SE, Gursoy-Ozdemir Y, Lule S, Eren-Ko\u00e7ak E, Duygu Sen Z, Dalkara T (2013) Spreading depression triggers headache by activating neuronal Panx1 channels. Science (New York, N.Y.) 339(6123):1092\u201395. https:\/\/doi.org\/10.1126\/science.1231897","journal-title":"Science (New York, N.Y.)"},{"issue":"12","key":"2444_CR78","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41582-018-0098-4","volume":"14","author":"N Karsan","year":"2018","unstructured":"Karsan N, Goadsby PJ (2018) Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol 14(12):699\u2013710. https:\/\/doi.org\/10.1038\/s41582-018-0098-4","journal-title":"Nat Rev Neurol"},{"issue":"4-Headache","key":"2444_CR79","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1212\/CON.0000000000000624","volume":"24","author":"Nazia Karsan","year":"2018","unstructured":"Karsan Nazia, Bose Pyari, Goadsby Peter J (2018) The migraine premonitory phase. Continuum (Minneap Minn) 24(4-Headache):996\u20131008. https:\/\/doi.org\/10.1212\/CON.0000000000000624","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"2444_CR80","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1212\/wnl.55.1.139","volume":"55","author":"H Kaube","year":"2000","unstructured":"Kaube H, Herzog J, K\u00e4ufer T, Dichgans M, Diener HC (2000) Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 55(1):139\u2013141. https:\/\/doi.org\/10.1212\/wnl.55.1.139","journal-title":"Neurology"},{"issue":"4","key":"2444_CR81","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.pbb.2009.11.012","volume":"94","author":"S Kert\u00e9sz","year":"2010","unstructured":"Kert\u00e9sz S, Kapus G, Gacs\u00e1lyi I, L\u00e9vay G (2010) Deramciclane improves object recognition in rats: potential role of NMDA receptors. Pharmacol Biochem Behav 94(4):570\u2013574. https:\/\/doi.org\/10.1016\/j.pbb.2009.11.012","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"2444_CR82","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/JAD-161251","volume":"57","author":"T Kishi","year":"2017","unstructured":"Kishi T, Matsunaga S, Iwata N (2017) A meta-analysis of memantine for depression. J Alzheimers Dis 57(1):113\u2013121. https:\/\/doi.org\/10.3233\/JAD-161251","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2444_CR83","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00008506-200101000-00005","volume":"13","author":"Y Kitahara","year":"2001","unstructured":"Kitahara Y, Taga K, Abe H, Shimoji K (2001) The effects of anesthetics on cortical spreading depression elicitation and C-Fos expression in rats. J Neurosurg Anesthesiol 13(1):26\u201332. https:\/\/doi.org\/10.1097\/00008506-200101000-00005","journal-title":"J Neurosurg Anesthesiol"},{"issue":"August","key":"2444_CR84","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pbb.2013.05.005","volume":"109","author":"SE Kotermanski","year":"2013","unstructured":"Kotermanski SE, Johnson JW, Thiels E (2013) Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats. Pharmacol Biochem Behav 109(August):67\u201376. https:\/\/doi.org\/10.1016\/j.pbb.2013.05.005","journal-title":"Pharmacol Biochem Behav"},{"issue":"12","key":"2444_CR85","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1097\/00001756-199908200-00039","volume":"10","author":"H Kr\u00fcger","year":"1999","unstructured":"Kr\u00fcger H, Heinemann U, Luhmann HJ (1999) Effects of ionotropic glutamate receptor blockade and 5-HT(1A) receptor activation on spreading depression in rat neocortical slices. NeuroReport 10(12):2651\u20132656. https:\/\/doi.org\/10.1097\/00001756-199908200-00039","journal-title":"NeuroReport"},{"issue":"4","key":"2444_CR86","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jpain.2008.01.139","volume":"9","author":"J Krusz","year":"2008","unstructured":"Krusz J, Cagle J, Hall S (2008a) (218) efficacy of IV ketamine in treating refractory migraines in the clinic. J Pain 9(4):30. https:\/\/doi.org\/10.1016\/j.jpain.2008.01.139","journal-title":"J Pain"},{"key":"2444_CR87","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jpain.2008.01.140","volume":"9","author":"J Krusz","year":"2008","unstructured":"Krusz J, Cagle J, Hall S (2008b) (219) intramuscular (IM) ketamine for treating headache and pain flare-ups in the clinic. In the Journal of Pain 9:30. https:\/\/doi.org\/10.1016\/j.jpain.2008.01.140","journal-title":"In the Journal of Pain"},{"key":"2444_CR88","doi-asserted-by":"publisher","unstructured":"Krzystanek M, Surma S, Pa\u0142asz A, Roma\u0144czyk M, Krysta K (2021) Possible antidepressant effects of memantine-systematic review with a case study. Pharmaceuticals 14 (5). https:\/\/doi.org\/10.3390\/ph14050481.","DOI":"10.3390\/ph14050481"},{"issue":"April","key":"2444_CR89","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuropharm.2012.10.018","volume":"67","author":"C Kudo","year":"2013","unstructured":"Kudo C, Toyama M, Boku A, Hanamoto H, Morimoto Y, Sugimura M, Niwa H (2013) Anesthetic effects on susceptibility to cortical spreading depression. Neuropharmacology 67(April):32\u201336. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.10.018","journal-title":"Neuropharmacology"},{"issue":"7","key":"2444_CR90","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/ejp.1393","volume":"23","author":"R Kurian","year":"2019","unstructured":"Kurian R, Raza K, Shanthanna H (2019) A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain. Eur J Pain (London, England) 23(7):1234\u20131250. https:\/\/doi.org\/10.1002\/ejp.1393","journal-title":"Eur J Pain (London, England)"},{"issue":"6","key":"2444_CR91","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11910-020-01037-3","volume":"20","author":"J Lai","year":"2020","unstructured":"Lai J, Dilli E (2020) Migraine aura: updates in pathophysiology and management. Curr Neurol Neurosci Rep 20(6):17. https:\/\/doi.org\/10.1007\/s11910-020-01037-3","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"2444_CR92","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s10194-016-0700-3","volume":"17","author":"C Lauritsen","year":"2016","unstructured":"Lauritsen C, Mazuera S, Lipton RB, Ashina S (2016) Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series. J Headache Pain 17(1):106. https:\/\/doi.org\/10.1186\/s10194-016-0700-3","journal-title":"J Headache Pain"},{"issue":"1","key":"2444_CR93","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0166-2236(87)90115-9","volume":"10","author":"M Lauritzen","year":"1987","unstructured":"Lauritzen M (1987) Cortical spreading depression as a putative migraine mechanism. Trends Neurosci 10(1):8\u201313. https:\/\/doi.org\/10.1016\/0166-2236(87)90115-9","journal-title":"Trends Neurosci"},{"issue":"2","key":"2444_CR94","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/jcbfm.1992.32","volume":"12","author":"M Lauritzen","year":"1992","unstructured":"Lauritzen M, Hansen AJ (1992) The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J Cereb Blood Flow Metab 12(2):223\u2013229. https:\/\/doi.org\/10.1038\/jcbfm.1992.32","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"2444_CR95","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1152\/jn.1944.7.6.359","volume":"7","author":"AAP Le\u00e3o","year":"1944","unstructured":"Le\u00e3o AAP (1944) Spreading depression of activity in the cerebral cortex. J Neurophysiol 7(6):359\u2013390. https:\/\/doi.org\/10.1152\/jn.1944.7.6.359","journal-title":"J Neurophysiol"},{"issue":"2","key":"2444_CR96","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/bcpt.12479","volume":"118","author":"S-H Lee","year":"2016","unstructured":"Lee S-H, Kim S-H, Noh Y-H, Choi B-M, Noh G-J, Park W-D, Kim E-J, Cho I-H, Bae C-S (2016) Pharmacokinetics of memantine after a single and multiple dose of oral and patch administration in rats. Basic Clin Pharmacol Toxicol 118(2):122\u2013127. https:\/\/doi.org\/10.1111\/bcpt.12479","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2444_CR97","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","volume":"10","author":"L Li","year":"2016","unstructured":"Li L, Vlisides PE (2016) Ketamine: 50 years of modulating the mind. Front Hum Neurosci 10:612","journal-title":"Front Hum Neurosci"},{"issue":"Suppl 2","key":"2444_CR98","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1007\/s10072-006-0582-2","volume":"27","author":"M Longoni","year":"2006","unstructured":"Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 27(Suppl 2):S107\u2013S110. https:\/\/doi.org\/10.1007\/s10072-006-0582-2","journal-title":"Neurol Sci"},{"issue":"2","key":"2444_CR99","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/brain\/awy325","volume":"142","author":"ICM Loonen","year":"2019","unstructured":"Loonen ICM, Jansen NA, Cain SM, Schenke M, Voskuyl RA, Yung AC, Bohnet B et al (2019) Brainstem Spreading depolarization and cortical dynamics during fatal seizures in Cacna1a S218L mice. Brain A J Neurol 142(2):412\u2013425. https:\/\/doi.org\/10.1093\/brain\/awy325","journal-title":"Brain A J Neurol"},{"issue":"5","key":"2444_CR100","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s42399-020-00298-w","volume":"2","author":"T Ma","year":"2020","unstructured":"Ma T, Cheng Q, Chen C, Luo Z, Feng D (2020) Excessive activation of NMDA receptors in the pathogenesis of multiple peripheral organs via mitochondrial dysfunction, oxidative stress, and inflammation. SN Comprehensive Clinical Medicine 2(5):551\u2013569. https:\/\/doi.org\/10.1007\/s42399-020-00298-w","journal-title":"SN Comprehensive Clinical Medicine"},{"issue":"2","key":"2444_CR101","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/0006-8993(88)90690-7","volume":"457","author":"R Marrannes","year":"1988","unstructured":"Marrannes R, Willems R, De Prins E, Wauquier A (1988) Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res 457(2):226\u2013240. https:\/\/doi.org\/10.1016\/0006-8993(88)90690-7","journal-title":"Brain Res"},{"issue":"2","key":"2444_CR102","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0304-3940(94)90540-1","volume":"180","author":"H Martin","year":"1994","unstructured":"Martin H, Warner DS, Todd MM (1994) Effects of glycine receptor antagonism on spreading depression in the rat. Neurosci Lett 180(2):285\u2013289. https:\/\/doi.org\/10.1016\/0304-3940(94)90540-1","journal-title":"Neurosci Lett"},{"issue":"2","key":"2444_CR103","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1046\/j.1468-2982.1993.1302089.x","volume":"13","author":"F Mart\u00ednez","year":"1993","unstructured":"Mart\u00ednez F, Castillo J, Rodr\u00edguez JR, Leira R, Noya M (1993) Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia 13(2):89\u201393. https:\/\/doi.org\/10.1046\/j.1468-2982.1993.1302089.x","journal-title":"Cephalalgia"},{"key":"2444_CR104","doi-asserted-by":"publisher","unstructured":"Masvidal-Codina E, Smith TM, Rathore D, Gao Y, Illa X, Prats-Alfonso E, Del Corro E et al (2021) Characterization of optogenetically-induced cortical spreading depression in awake mice using graphene micro-transistor arrays. J Neural Eng 18 (5). https:\/\/doi.org\/10.1088\/1741-2552\/abecf3","DOI":"10.1088\/1741-2552\/abecf3"},{"issue":"10","key":"2444_CR105","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/14740338.2018.1524870","volume":"17","author":"S Matsunaga","year":"2018","unstructured":"Matsunaga S, Kishi T, Nomura I, Sakuma K, Okuya M, Ikuta T, Iwata N (2018) the efficacy and safety of memantine for the treatment of Alzheimer\u2019s disease. Expert Opin Drug Saf 17(10):1053\u20131061. https:\/\/doi.org\/10.1080\/14740338.2018.1524870","journal-title":"Expert Opin Drug Saf"},{"key":"2444_CR106","doi-asserted-by":"publisher","first-page":"105071","DOI":"10.1016\/j.nbd.2020.105071","volume":"145","author":"Y-Y Mei","year":"2020","unstructured":"Mei Y-Y, Lee M-H, Cheng T-C, Hsiao I-H, Wu DC, Zhou N (2020) NMDA receptors sustain but do not initiate neuronal depolarization in spreading depolarization. Neurobiol Dis 145:105071. https:\/\/doi.org\/10.1016\/j.nbd.2020.105071","journal-title":"Neurobiol Dis"},{"issue":"7","key":"2444_CR107","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jnnp-2015-312233","volume":"87","author":"MT Minen","year":"2016","unstructured":"Minen MT, Dhaem OBD, Diest AKV, Powers S, Schwedt TJ, Lipton R, Silbersweig D (2016) Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 87(7):741\u2013749. https:\/\/doi.org\/10.1136\/jnnp-2015-312233","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2444_CR108","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cns.12099","volume":"19","author":"G Mion","year":"2013","unstructured":"Mion G, Villevieille T (2013) Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther 19(6):370\u2013380. https:\/\/doi.org\/10.1111\/cns.12099","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"2444_CR109","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/WCO.0000000000000547","volume":"31","author":"F Naeem","year":"2018","unstructured":"Naeem F, Schramm C, Friedman BW (2018) Emergent management of primary headache: a review of current literature. Curr Opin Neurol 31(3):286\u2013290. https:\/\/doi.org\/10.1097\/WCO.0000000000000547","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"2444_CR110","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1748-1716.1992.tb09451.x","volume":"146","author":"B Nellg\u00e5rd","year":"1992","unstructured":"Nellg\u00e5rd B, Wieloch T (1992) NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Acta Physiol Scand 146(4):497\u2013503. https:\/\/doi.org\/10.1111\/j.1748-1716.1992.tb09451.x","journal-title":"Acta Physiol Scand"},{"issue":"5\u20136","key":"2444_CR111","first-page":"181","volume":"15","author":"M Nicolodi","year":"1995","unstructured":"Nicolodi M, Sicuteri F (1995) Exploration of NMDA receptors in migraine: therapeutic and theoretic implications. Int J Clin Pharmacol Res 15(5\u20136):181\u2013189","journal-title":"Int J Clin Pharmacol Res"},{"issue":"1","key":"2444_CR112","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/head.12732","volume":"56","author":"R Noruzzadeh","year":"2016","unstructured":"Noruzzadeh R, Modabbernia A, Aghamollaii V, Ghaffarpour M, Harirchian MH, Salahi S, Nikbakht N, Noruzi N, Tafakhori A (2016) Memantine for prophylactic treatment of migraine without aura: a randomized double-blind placebo-controlled study. Headache 56(1):95\u2013103. https:\/\/doi.org\/10.1111\/head.12732","journal-title":"Headache"},{"issue":"1","key":"2444_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Jes Olesen","year":"2018","unstructured":"Olesen Jes (2018) Headache classification committee of the international headache society (IHS) the international classification of headache disorders , 3rd Edition. Cephalalgia 38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"issue":"9","key":"2444_CR114","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1097\/j.pain.0000000000001894","volume":"161","author":"GLJ Onderwater","year":"2020","unstructured":"Onderwater GLJ, Dool J, Ferrari MD, Terwindt GM (2020) Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control study. Pain 161(9):2058\u20132067. https:\/\/doi.org\/10.1097\/j.pain.0000000000001894","journal-title":"Pain"},{"issue":"2","key":"2444_CR115","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","volume":"15","author":"JJY Ong","year":"2018","unstructured":"Ong JJY, De Felice M (2018) Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics 15(2):274\u201390. https:\/\/doi.org\/10.1007\/s13311-017-0592-1","journal-title":"Neurotherapeutics"},{"key":"2444_CR116","doi-asserted-by":"publisher","unstructured":"Pacheco JM, Hines-Lanham A, Stratton C, Mehos CJ, McCurdy KE, Pinkowski NJ, Zhang H, Shuttleworth CW, Morton RA (2019) Spreading depolarizations occur in mild traumatic brain injuries and are associated with postinjury behavior. ENeuro 6 (6): ENEURO.0070\u201319.2019: 1\u201317. https:\/\/doi.org\/10.1523\/ENEURO.0070-19.2019","DOI":"10.1523\/ENEURO.0070-19.2019"},{"issue":"6","key":"2444_CR117","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","volume":"14","author":"Pi Paoletti","year":"2013","unstructured":"Paoletti Pi, Bellone C, Zhou Q (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14(6):383\u2013400","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"2444_CR118","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","volume":"53","author":"CG Parsons","year":"2007","unstructured":"Parsons CG, St\u00f6ffler A, Danysz W (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse. Neuropharmacology 53(6):699\u2013723","journal-title":"Neuropharmacology"},{"key":"2444_CR119","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnsyn.2014.00010","volume":"6","author":"P Paul","year":"2014","unstructured":"Paul P, de Belleroche J (2014) The role of D-serine and glycine as co-agonists of NMDA receptors in motor neuron degeneration and amyotrophic lateral sclerosis (ALS). Front Synaptic Neurosci 6:10. https:\/\/doi.org\/10.3389\/fnsyn.2014.00010","journal-title":"Front Synaptic Neurosci"},{"issue":"2","key":"2444_CR120","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1124\/jpet.106.117101","volume":"321","author":"M Peeters","year":"2007","unstructured":"Peeters M, Gunthorpe MJ, Strijbos PJLM, Goldsmith P, Upton N, James MF (2007) Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine. J Pharmacol Exp Ther 321(2):564\u2013572. https:\/\/doi.org\/10.1124\/jpet.106.117101","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"2444_CR121","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","volume":"55","author":"MA Peltoniemi","year":"2016","unstructured":"Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI (2016) Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet 55(9):1059\u20131077. https:\/\/doi.org\/10.1007\/s40262-016-0383-6","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"2444_CR122","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1468-2982.2004.00750.x","volume":"24","author":"MFP Peres","year":"2004","unstructured":"Peres MFP, Zukerman E, Senne Soares CA, Alonso EO, Santos BFC, Faulhaber MHW (2004) Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia 24(9):735\u2013739. https:\/\/doi.org\/10.1111\/j.1468-2982.2004.00750.x","journal-title":"Cephalalgia"},{"issue":"5","key":"2444_CR123","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","volume":"176","author":"JL Phillips","year":"2019","unstructured":"Phillips JL, Norris S, Talbot J, Birmingham M, Hatchard T, Ortiz A, Owoeye O, Batten LA, Blier P (2019) Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial. Am J Psychiatry 176(5):401\u2013409. https:\/\/doi.org\/10.1176\/appi.ajp.2018.18070834","journal-title":"Am J Psychiatry"},{"issue":"1","key":"2444_CR124","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/fcp.12316","volume":"32","author":"G Pickering","year":"2018","unstructured":"Pickering G, Morel V (2018) Memantine for the treatment of general neuropathic pain: a narrative review. Fundam Clin Pharmacol 32(1):4\u201313. https:\/\/doi.org\/10.1111\/fcp.12316","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"2444_CR125","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-physiol-030212-183717","volume":"75","author":"D Pietrobon","year":"2013","unstructured":"Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annu Rev Physiol 75(1):365\u2013391. https:\/\/doi.org\/10.1146\/annurev-physiol-030212-183717","journal-title":"Annu Rev Physiol"},{"issue":"8","key":"2444_CR126","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s40265-015-0400-3","volume":"75","author":"GL Plosker","year":"2015","unstructured":"Plosker GL (2015) Memantine extended release (28 mg once daily): a review of its use in Alzheimer\u2019s disease. Drugs 75(8):887\u2013897. https:\/\/doi.org\/10.1007\/s40265-015-0400-3","journal-title":"Drugs"},{"issue":"11","key":"2444_CR127","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/14737175.2019.1643237","volume":"19","author":"B Pochwat","year":"2019","unstructured":"Pochwat B, Nowak G, Szewczyk B (2019) An update on NMDA antagonists in depression. Expert Rev Neurother 19(11):1055\u20131067. https:\/\/doi.org\/10.1080\/14737175.2019.1643237","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"2444_CR128","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/head.13013","volume":"57","author":"JL Pomeroy","year":"2017","unstructured":"Pomeroy JL, Marmura MJ, Nahas SJ, Viscusi ER (2017) Ketamine infusions for treatment refractory headache. Headache 57(2):276\u2013282. https:\/\/doi.org\/10.1111\/head.13013","journal-title":"Headache"},{"issue":"1","key":"2444_CR129","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2478\/rjaic-2019-0010","volume":"26","author":"SB Porter","year":"2019","unstructured":"Porter SB (2019) Perioperative ketamine for acute analgesia and beyond. Rom J Anaesth Intensive Care 26(1):67\u201373. https:\/\/doi.org\/10.2478\/rjaic-2019-0010","journal-title":"Rom J Anaesth Intensive Care"},{"issue":"9","key":"2444_CR130","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1468-2982.2006.01157.x","volume":"26","author":"E Quintela","year":"2006","unstructured":"Quintela E, Castillo J, Mu\u00f1oz P, Pascual J (2006) Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients. Cephalalgia 26(9):1051\u20131060. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01157.x","journal-title":"Cephalalgia"},{"issue":"1\u20132","key":"2444_CR131","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/0006-8993(95)00692-j","volume":"693","author":"A Rashidy-Pour","year":"1995","unstructured":"Rashidy-Pour A, Motaghed-Larijani Z, Bures J (1995) Tolerance to ketamine-induced blockade of cortical spreading depression transfers to MK-801 but not to AP5 in rats. Brain Res 693(1\u20132):64\u201369. https:\/\/doi.org\/10.1016\/0006-8993(95)00692-j","journal-title":"Brain Res"},{"issue":"2","key":"2444_CR132","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/BF03011442","volume":"36","author":"DL Reich","year":"1989","unstructured":"Reich DL, Silvay G (1989) Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 36(2):186\u201397. https:\/\/doi.org\/10.1007\/BF03011442","journal-title":"Can J Anaesth"},{"key":"2444_CR133","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/J.EXPNEUROL.2018.04.007","volume":"305","author":"KM Reinhart","year":"2018","unstructured":"Reinhart KM, Shuttleworth C (2018) Ketamine reduces deleterious consequences of spreading depolarizations. Exp Neurol 305:121\u2013128. https:\/\/doi.org\/10.1016\/J.EXPNEUROL.2018.04.007","journal-title":"Exp Neurol"},{"issue":"Suppl 2","key":"2444_CR134","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12028-021-01351-9","volume":"35","author":"KM Reinhart","year":"2021","unstructured":"Reinhart KM, Humphrey A, Brennan KC, Carlson AP, Shuttleworth CW (2021) Memantine improves recovery after spreading depolarization in brain slices and can be considered for future clinical trials. Neurocritical Care 35(Suppl 2):135\u201345. https:\/\/doi.org\/10.1007\/s12028-021-01351-9","journal-title":"Neurocritical Care"},{"issue":"2","key":"2444_CR135","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbrc.2017.11.203","volume":"496","author":"C Ren","year":"2018","unstructured":"Ren C, Liu J, Zhou J, Liang H, Wang Y, Sun Y, Ma B, Yin Y (2018) Low levels of serum serotonin and amino acids identified in migraine patients. Biochem Biophys Res Commun 496(2):267\u2013273. https:\/\/doi.org\/10.1016\/j.bbrc.2017.11.203","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2444_CR136","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11910-020-01030-w","volume":"20","author":"J Robblee","year":"2020","unstructured":"Robblee J, Grimsrud KW (2020) Emergency department and inpatient management of headache in adults. Curr Neurol Neurosci Rep 20(4):7. https:\/\/doi.org\/10.1007\/s11910-020-01030-w","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"2444_CR137","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/archneur.65.6.709","volume":"65","author":"MA Rogawski","year":"2008","unstructured":"Rogawski MA (2008) Common pathophysiologic mechanisms in migraine and epilepsy. Arch Neurol 65(6):709\u2013714. https:\/\/doi.org\/10.1001\/archneur.65.6.709","journal-title":"Arch Neurol"},{"key":"2444_CR138","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neuropharm.2014.04.018","volume":"84","author":"R S\u00e1nchez-Porras","year":"2014","unstructured":"S\u00e1nchez-Porras R, Santos E, Sch\u00f6ll M, Stock C, Zheng Z, Schiebel P, Orakcioglu B, Unterberg AW, Sakowitz OW (2014) The effect of ketamine on optical and electrical characteristics of spreading depolarizations in gyrencephalic swine cortex. Neuropharmacology 84:52\u201361. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.04.018","journal-title":"Neuropharmacology"},{"key":"2444_CR139","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-319-04981-6_26","volume":"120","author":"R S\u00e1nchez-Porras","year":"2015","unstructured":"S\u00e1nchez-Porras R, Zheng Z, Sakowitz OW (2015) Pharmacological modulation of spreading depolarizations. Acta Neurochir Suppl 120:153\u2013157. https:\/\/doi.org\/10.1007\/978-3-319-04981-6_26","journal-title":"Acta Neurochir Suppl"},{"issue":"5","key":"2444_CR140","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1177\/0271678X16646586","volume":"37","author":"R S\u00e1nchez-Porras","year":"2017","unstructured":"S\u00e1nchez-Porras R, Santos E, Sch\u00f6ll M, Kunzmann K, Stock C, Silos H, Unterberg AW, Sakowitz OW (2017) Ketamine modulation of the haemodynamic response to spreading depolarization in the gyrencephalic swine brain. J Cereb Blood Flow Metab 37(5):1720\u20131734. https:\/\/doi.org\/10.1177\/0271678X16646586","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"2444_CR141","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s13054-019-2711-3","volume":"23","author":"E Santos","year":"2019","unstructured":"Santos E, Olivares-Rivera A, Major S, S\u00e1nchez-Porras R, Uhlmann L, Kunzmann K, Zerelles R et al (2019) Lasting S-ketamine block of spreading depolarizations in subarachnoid hemorrhage: a retrospective cohort study. Critical Care (London, England) 23(1):427. https:\/\/doi.org\/10.1186\/s13054-019-2711-3","journal-title":"Critical Care (London, England)"},{"issue":"3\u20134","key":"2444_CR142","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s007260070007","volume":"19","author":"D Scheller","year":"2000","unstructured":"Scheller D, Szathmary S, Kolb J, Tegtmeier F (2000) Observations on the relationship between the extracellular changes of taurine and glutamate during cortical spreading depression, during ischemia, and within the area surrounding a thrombotic infarct. Amino Acids 19(3\u20134):571\u2013583. https:\/\/doi.org\/10.1007\/s007260070007","journal-title":"Amino Acids"},{"issue":"3","key":"2444_CR143","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrneurol.2010.14","volume":"6","author":"AI Scher","year":"2010","unstructured":"Scher AI, Launer LJ (2010) Migraine: migraine with aura increases the risk of stroke. Nat Rev Neurol 6(3):128\u2013129. https:\/\/doi.org\/10.1038\/nrneurol.2010.14","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2444_CR144","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0304-3959(99)00044-5","volume":"82","author":"RL Schmid","year":"1999","unstructured":"Schmid RL, Sandler AN, Katz J (1999) Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain 82(2):111\u2013125","journal-title":"Pain"},{"issue":"2","key":"2444_CR145","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/eb-2016-102355","volume":"19","author":"J Schwartz","year":"2016","unstructured":"Schwartz J, Murrough JW, Iosifescu DV (2016) Ketamine for treatment-resistant depression: recent developments and clinical applications. Evid Based Ment Health 19(2):35\u201338. https:\/\/doi.org\/10.1136\/eb-2016-102355","journal-title":"Evid Based Ment Health"},{"issue":"8","key":"2444_CR146","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/AAP.0000000000000827","volume":"43","author":"ES Schwenk","year":"2018","unstructured":"Schwenk ES, Dayan AC, Rangavajjula A, Torjman MC, Hernandez MG, Lauritsen CG, Silberstein SD, Young W, Viscusi ER (2018) Ketamine for refractory headache: a retrospective analysis. Reg Anesth Pain Med 43(8):875\u2013879. https:\/\/doi.org\/10.1097\/AAP.0000000000000827","journal-title":"Reg Anesth Pain Med"},{"issue":"11","key":"2444_CR147","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/jcph.1920","volume":"61","author":"ES Schwenk","year":"2021","unstructured":"Schwenk ES, Torjman MC, Moaddel R, Lovett J, Katz D, Denk W, Lauritsen C, Silberstein SD, Wainer IW (2021) Ketamine for refractory chronic migraine: an observational pilot study and metabolite analysis. J Clin Pharmacol 61(11):1421\u20131429. https:\/\/doi.org\/10.1002\/jcph.1920","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"2444_CR148","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4103\/aian.AIAN_294_18","volume":"22","author":"S Shanmugam","year":"2019","unstructured":"Shanmugam S, Karunaikadal K, Varadarajan S, Krishnan M (2019) Memantine ameliorates migraine headache. Ann Indian Acad Neurol 22(3):286\u2013290. https:\/\/doi.org\/10.4103\/aian.AIAN_294_18","journal-title":"Ann Indian Acad Neurol"},{"issue":"11","key":"2444_CR149","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.4103\/1673-5374.194759","volume":"11","author":"P-P Shen","year":"2016","unstructured":"Shen P-P, Hou S, Ma Di, Zhao M-M, Zhu M-Q, Zhang J-D, Feng L-S, Cui Li, Feng J-C (2016) Cortical spreading depression-induced preconditioning in the brain. Neural Regen Res 11(11):1857\u20131864. https:\/\/doi.org\/10.4103\/1673-5374.194759","journal-title":"Neural Regen Res"},{"key":"2444_CR150","unstructured":"Shiguetomi-Medina JM (2020) Comparative study between valproate and memantine in the prophylactic management of episodic migraine. 2020. \nhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT04698525. Accessed 20 June 2022"},{"issue":"2\u20133","key":"2444_CR151","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tacc.2014.03.002","volume":"4","author":"J Sleigh","year":"2014","unstructured":"Sleigh J, Harvey M, Voss L, Denny B (2014) Ketamine - more mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care 4(2\u20133):76\u201381. https:\/\/doi.org\/10.1016\/j.tacc.2014.03.002","journal-title":"Trends Anaesth Crit Care"},{"issue":"2","key":"2444_CR152","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1526-4610.2007.01016.x","volume":"48","author":"K Spengos","year":"2008","unstructured":"Spengos K, Theleritis C, Paparrigopoulos T (2008) Memantine and NMDA antagonism for chronic migraine: a potentially novel therapeutic approach? Headache 48(2):284\u2013286. https:\/\/doi.org\/10.1111\/j.1526-4610.2007.01016.x","journal-title":"Headache"},{"issue":"3","key":"2444_CR153","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1213\/01.ane.0000231635.14872.40","volume":"103","author":"T Sprenger","year":"2006","unstructured":"Sprenger T, Valet M, Woltmann R, Zimmer C, Freynhagen R, Kochs EF, T\u00f6lle TR, Wagner KJ (2006) Imaging pain modulation by subanesthetic S-(+)-ketamine. Anesth Analg 103(3):729\u2013737. https:\/\/doi.org\/10.1213\/01.ane.0000231635.14872.40","journal-title":"Anesth Analg"},{"issue":"9","key":"2444_CR154","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1177\/0271678X16657836","volume":"36","author":"AI Srienc","year":"2016","unstructured":"Srienc AI, Biesecker KR, Shimoda AM, Kur J, Newman EA (2016) Ischemia-induced spreading depolarization in the retina. J Cereb Blood Flow Metab 36(9):1579\u20131591. https:\/\/doi.org\/10.1177\/0271678X16657836","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"2444_CR155","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z (2020) Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain 21(1):137. https:\/\/doi.org\/10.1186\/s10194-020-01208-0","journal-title":"J Headache Pain"},{"issue":"1","key":"2444_CR156","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/JCP.0b013e3181c856de","volume":"30","author":"SE Stewart","year":"2010","unstructured":"Stewart SE, Jenike EA, Hezel DM, Stack DE, Dodman NH, Shuster L, Jenike MA (2010) A single-blinded case-control study of memantine in severe obsessive-compulsive disorder. J Clin Psychopharmacol 30(1):34\u201339. https:\/\/doi.org\/10.1097\/JCP.0b013e3181c856de","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl. 1","key":"2444_CR157","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/J.1468-2982.2009.01960.X","volume":"29","author":"RJ Storer","year":"2009","unstructured":"Storer RJ, Goadsby PJ (2009) N-Methyl-d-aspartate receptor channel complex blockers including memantine and magnesium inhibit nociceptive traffic in the trigeminocervical complex of the rat. Cephalalgia 29(Suppl. 1):135. https:\/\/doi.org\/10.1111\/J.1468-2982.2009.01960.X","journal-title":"Cephalalgia"},{"issue":"12","key":"2444_CR158","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1161\/01.str.0000043073.69602.09","volume":"33","author":"AJ Strong","year":"2002","unstructured":"Strong AJ, Fabricius M, Boutelle MG, Hibbins SJ, Hopwood SE, Jones R, Parkin MC, Lauritzen M (2002) Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke 33(12):2738\u20132743. https:\/\/doi.org\/10.1161\/01.str.0000043073.69602.09","journal-title":"Stroke"},{"key":"2444_CR159","doi-asserted-by":"publisher","unstructured":"Sutherland HG, Albury CL, Griffiths LR (2019) Advances in Genetics of Migraine.J Headache Pain 20(1):72. https:\/\/doi.org\/10.1186\/s10194-019-1017-9","DOI":"10.1186\/s10194-019-1017-9"},{"issue":"10","key":"2444_CR160","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/14737175.2019.1640604","volume":"19","author":"J Swainson","year":"2019","unstructured":"Swainson J, Thomas RK, Archer S, Chrenek C, MacKay M-A, Baker G, Dursun S, Klassen LJ, Chokka P, Demas ML (2019) Esketamine for treatment resistant depression. Expert Rev Neurother 19(10):899\u2013911. https:\/\/doi.org\/10.1080\/14737175.2019.1640604","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"2444_CR161","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/00000542-199710000-00027","volume":"87","author":"K Taga","year":"1997","unstructured":"Taga K, Patel PM, Drummond JC, Cole DJ, Kelly PJ (1997) Transient neuronal depolarization induces tolerance to subsequent forebrain ischemia in rats. Anesthesiology 87(4):918\u2013925. https:\/\/doi.org\/10.1097\/00000542-199710000-00027","journal-title":"Anesthesiology"},{"issue":"5","key":"2444_CR162","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00702-012-0788-9","volume":"119","author":"J Tajti","year":"2012","unstructured":"Tajti J, Szok D, P\u00e1rdutz \u00c1, Tuka B, Cs\u00e1ti A, Kuris A, Toldi J, V\u00e9csei L (2012) Where does a migraine attack originate? In the Brainstem. J Neural Transm (Vienna, Austria: 1996) 119(5):557\u201368. https:\/\/doi.org\/10.1007\/s00702-012-0788-9","journal-title":"J Neural Transm (Vienna, Austria: 1996)"},{"key":"2444_CR163","doi-asserted-by":"publisher","unstructured":"Tardiolo G, Bramanti P, Mazzon E (2019) Migraine: experimental models and novel therapeutic approaches. Int J Mol Sci 20(12). https:\/\/doi.org\/10.3390\/ijms20122932","DOI":"10.3390\/ijms20122932"},{"issue":"11","key":"2444_CR164","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1177\/0333102415623070","volume":"36","author":"AF Tipton","year":"2016","unstructured":"Tipton AF, Tarash I, McGuire B, Charles A, Pradhan AA (2016) The effects of acute and preventive migraine therapies in a mouse model of chronic migraine. Cephalalgia 36(11):1048\u20131056. https:\/\/doi.org\/10.1177\/0333102415623070","journal-title":"Cephalalgia"},{"issue":"3","key":"2444_CR165","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62(3):405\u2013496","journal-title":"Pharmacol Rev"},{"key":"2444_CR166","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pediatrneurol.2019.10.007","volume":"104","author":"AL Turner","year":"2020","unstructured":"Turner AL, Shandley S, Ean Miller M, Perry S, Ryals B (2020) Intranasal ketamine for abortive migraine therapy in pediatric patients: a single-center review. Pediatr Neurol 104:46\u201353. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2019.10.007","journal-title":"Pediatr Neurol"},{"issue":"9","key":"2444_CR167","first-page":"842","volume":"171","author":"LF Van Pelt","year":"1977","unstructured":"Van Pelt LF (1977) Ketamine and xylazine for surgical anesthesia in rats. J Am Vet Med Assoc 171(9):842\u2013844","journal-title":"J Am Vet Med Assoc"},{"issue":"1","key":"2444_CR168","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0006-8993(92)90355-D","volume":"581","author":"M Verhaegen","year":"1992","unstructured":"Verhaegen M, Todd MM, Warner DS (1992) The influence of different concentrations of volatile anesthetics on the threshold for cortical spreading depression in Rats. Brain Res 581(1):153\u2013155. https:\/\/doi.org\/10.1016\/0006-8993(92)90355-D","journal-title":"Brain Res"},{"issue":"1","key":"2444_CR169","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11064-019-02750-3","volume":"45","author":"A Verkhratsky","year":"2020","unstructured":"Verkhratsky A, Chv\u00e1tal A (2020) NMDA receptors in astrocytes. Neurochem Res 45(1):122\u2013133. https:\/\/doi.org\/10.1007\/s11064-019-02750-3","journal-title":"Neurochem Res"},{"issue":"12","key":"2444_CR170","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11916-018-0735-z","volume":"22","author":"A Vgontzas","year":"2018","unstructured":"Vgontzas A, Burch R (2018) Episodic migraine with and without aura: key differences and implications for pathophysiology, management, and assessing risks. Curr Pain Headache Rep 22(12):78. https:\/\/doi.org\/10.1007\/s11916-018-0735-z","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"2444_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-017-1438-4","volume":"391","author":"M Viana","year":"2018","unstructured":"Viana M, Afridi S (2018) Migraine with prolonged aura: phenotype and treatment. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 391(1):1\u20137. https:\/\/doi.org\/10.1007\/s00210-017-1438-4","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"10","key":"2444_CR172","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1080\/14737175.2021.1947797","volume":"21","author":"D Vuralli","year":"2021","unstructured":"Vuralli D, Karatas H, Yemisci M, Bolay H (2021) Updated review on the link between cortical spreading depression and headache disorders. Expert Rev Neurother 21(10):1069\u20131084. https:\/\/doi.org\/10.1080\/14737175.2021.1947797","journal-title":"Expert Rev Neurother"},{"key":"2444_CR173","doi-asserted-by":"publisher","unstructured":"Vyklicky V, Korinek M, Smejkalova T, Balik A, Krausova B, Kaniakova M, Lichnerova K et al (2014) Structure, function, and pharmacology of NMDA receptor channels. Physiol Res 63(Suppl 1): S191\u2013203. https:\/\/doi.org\/10.33549\/physiolres.932678","DOI":"10.33549\/physiolres.932678"},{"key":"2444_CR174","doi-asserted-by":"publisher","first-page":"106318","DOI":"10.1016\/j.clineuro.2020.106318","volume":"200","author":"S Wanchoo","year":"2021","unstructured":"Wanchoo S, Khazanehdari S, Patel A, Lin A, Rebeiz T, DeMatteo C, Ullman J, Ledoux D (2021) Ketamine for empiric treatment of cortical spreading depolarization after subdural hematoma evacuation. Clin Neurol Neurosurg 200:106318. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106318","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"2444_CR175","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH (2017) Role of glutamate and NMDA receptors in Alzheimer\u2019s disease. J Alzheimers Dis 57(4):1041\u201348. https:\/\/doi.org\/10.3233\/JAD-160763","journal-title":"J Alzheimers Dis"},{"key":"2444_CR176","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.pa.21.040181.001121","volume":"21","author":"JC Watkins","year":"1981","unstructured":"Watkins JC, Evans RH (1981) Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol 21:165\u2013204","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"2444_CR177","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","volume":"175","author":"NR Williams","year":"2018","unstructured":"Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, Hawkins J et al (2018) Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. Am J Psychiatry 175(12):1205\u20131215. https:\/\/doi.org\/10.1176\/appi.ajp.2018.18020138","journal-title":"Am J Psychiatry"},{"key":"2444_CR178","doi-asserted-by":"publisher","unstructured":"Williams BS, Buvanendran A (2010) Memantine. In The Essence of Analgesia and Analgesics, edited by J Michael Watkins-Pitchford, Jonathan S Jahr, and Raymond S Sinatra, 319\u201320. Cambridge. https:\/\/doi.org\/10.1017\/CBO9780511841378.077","DOI":"10.1017\/CBO9780511841378.077"},{"key":"2444_CR179","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev.pa.29.040189.002301","volume":"29","author":"JT Wroblewski","year":"1989","unstructured":"Wroblewski JT, Danysz W (1989) Modulation of glutamate receptors: molecular mechanisms and functional implications. Annu Rev Pharmacol Toxicol 29:441\u2013474. https:\/\/doi.org\/10.1146\/annurev.pa.29.040189.002301","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"2444_CR180","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13041-018-0357-8","volume":"11","author":"QJ Wu","year":"2018","unstructured":"Wu QJ, Tymianski M (2018) Targeting NMDA Receptors in stroke: new hope in neuroprotection. Mol Brain 11(1):15. https:\/\/doi.org\/10.1186\/s13041-018-0357-8","journal-title":"Mol Brain"},{"issue":"7","key":"2444_CR181","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/00004647-200207000-00008","volume":"22","author":"C Yokota","year":"2002","unstructured":"Yokota C, Kuge Y, Hasegawa Y, Tagaya M, Abumiya T, Ejima N, Tamaki N, Yamaguchi T, Minematsu K (2002) Unique profile of spreading depression in a primate model. J Cereb Blood Flow Metab 22(7):835\u2013842. https:\/\/doi.org\/10.1097\/00004647-200207000-00008","journal-title":"J Cereb Blood Flow Metab"},{"key":"2444_CR182","doi-asserted-by":"publisher","unstructured":"Yu A, Lau AY (2018) Glutamate and glycine binding to the NMDA receptor. Structure (London, England\u202f: 1993) 26 (7): 1035\u20131043.e2. https:\/\/doi.org\/10.1016\/j.str.2018.05.004","DOI":"10.1016\/j.str.2018.05.004"},{"issue":"3","key":"2444_CR183","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.117.015198","volume":"70","author":"P Zanos","year":"2018","unstructured":"Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EF et al (2018) Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev 70(3):621\u2013660","journal-title":"Pharmacol Rev"},{"issue":"8","key":"2444_CR184","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an NMDA antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63(8):856\u2013864","journal-title":"Arch Gen Psychiatry"},{"issue":"26","key":"2444_CR185","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1523\/JNEUROSCI.0511-10.2010","volume":"30","author":"X Zhang","year":"2010","unstructured":"Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R (2010) Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci 30(26):8807\u20138814. https:\/\/doi.org\/10.1523\/JNEUROSCI.0511-10.2010","journal-title":"J Neurosci"},{"issue":"3","key":"2444_CR186","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/svn-2017-000077","volume":"2","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Parikh A, Qian S (2017) Migraine and stroke. Stroke Vasc Neurol 2(3):160\u2013167. https:\/\/doi.org\/10.1136\/svn-2017-000077","journal-title":"Stroke Vasc Neurol"},{"issue":"8","key":"2444_CR187","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","volume":"121","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Danbolt NC (2014) Glutamate as a neurotransmitter in the healthy brain. J Neural Transm (Vienna, Austria: 1996) 121(8):799\u2013817. https:\/\/doi.org\/10.1007\/s00702-014-1180-8","journal-title":"J Neural Transm (Vienna, Austria: 1996)"},{"issue":"4","key":"2444_CR188","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/1073858414548724","volume":"21","author":"X Zhou","year":"2015","unstructured":"Zhou X, Chen Z, Yun W, Ren J, Li C, Wang H (2015) Extrasynaptic NMDA receptor in excitotoxicity: function revisited. Neuroscientist 21(4):337\u2013344. https:\/\/doi.org\/10.1177\/1073858414548724","journal-title":"Neuroscientist"},{"key":"2444_CR189","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neuropharm.2016.08.014","volume":"112","author":"M Zhuo","year":"2017","unstructured":"Zhuo M (2017) Ionotropic glutamate receptors contribute to pain transmission and chronic pain. Neuropharmacology 112:228\u2013234. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.08.014","journal-title":"Neuropharmacology"},{"issue":"7","key":"2444_CR190","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/brain\/awx130","volume":"140","author":"R Zielman","year":"2017","unstructured":"Zielman R, Wijnen JP, Webb A, Onderwater GLJ, Ronen I, Ferrari MD, Kan HE, Terwindt GM, Kruit MC (2017) Cortical glutamate in migraine. Brain 140(7):1859\u20131871. https:\/\/doi.org\/10.1093\/brain\/awx130","journal-title":"Brain"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02444-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02444-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02444-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T14:16:45Z","timestamp":1686061005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02444-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":190,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2444"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02444-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"29 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}